Log in
Enquire now
‌

US Patent 11584756 Heterocyclic compounds as BET inhibitors

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115847560
Date of Patent
February 21, 2023
0
Patent Application Number
169189970
Date Filed
July 1, 2020
0
Patent Citations
‌
US Patent 10053454 Carbazole compounds useful as bromodomain inhibitors
‌
US Patent 10059699 Tetrahydroquinoline derivatives as bromodomain inhibitors
‌
US Patent 10077259 Bicyclic heterocyclic derivatives as bromodomain inhibitors
‌
US Patent 10253044 9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors
‌
US Patent 10292968 Substituted heterocycles as bromodomain inhibitors
‌
US Patent 10307407 9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors
0
‌
US Patent 10328074 Substituted [1,2,4]triazolo[4,3-a]pyrazines as BRD4 inhibitors
‌
US Patent 10336697 Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors
0
...
Patent Primary Examiner
‌
Niloofar Rahmani
0
CPC Code
‌
C07D 495/04
0

Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11584756 Heterocyclic compounds as BET inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.